- By country
- By industry
- By topic
- Top 100
SOFIA (Bulgaria), December 6 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Friday that its CEO Ognyan Donev has acquired 10,189 shares in the company at a weighted average price per share of 3.4478 levs ($1.96/1.76 euro).
Donev acquired the shares through deals on the Bulgarian Stock Exchange on December 5, Sopharma said in a bourse filing.
The 23,771 shares are equal to a 0.0076% stake in Sopharma.
At the end of September, Donev held a stake of below 5% in Sopharma, according to the company's most recent interim financial statement.
However, Ognyan Donev is indirectly the biggest shareholder in Sopharma, as he controls a 25.39% stake through his company Donev Investments Holding. Donev is also a major shareholder in Sopharma's second biggest shareholder - Telecomplect Invest. Telecomplect Invest controls 20.68% interest in Sopharma.
As at 12:40 CET on Friday, Sopharma shares traded 0.58% lower at 3.43 levs on the Bulgarian Stock Exchange.
(1 euro = 1.95583 levs)